BioSpace News Archive

Gilead Sciences, Inc. announced the promotion of Andrew Dickinson to Executive Vice President, Corporate Development and Strategy.

AstraZeneca and Merck presented data which showed clinical improvement in median radiologic progression-free survival (rPFS) with LYNPARZA® (olaparib) in combination with abiraterone compared to abiraterone monotherapy, a current standard of care, in metastatic castration-resistant prostate cancer (mCRPC).

The Pharmaceutical Care Management Association (PCMA) released the following statement on a Medicare Part D report released today by the Office of Inspector (OIG), U.S. Department of Health and Human Services (HHS).

Neovasc Inc. is pleased to announce the results of the votes on matters considered at its Annual General and Special Meeting of Shareholders held on June 4, 2018 in Vancouver, B.C. (the “Meeting”).

Masimo announced today the findings of an abstract presented at Euroanaesthesia 2018 in which researchers compared Masimo noninvasive and continuous hemoglobin (SpHb®) to intermittent and invasive lab hemoglobin (LabHb) in reflecting iatrogenic hemodilution during incremental fluid administration of patients undergoing major surgery.

QIAGEN N.V. announced that it welcomes new guidelines from the American Academy of Pediatrics (AAP) that recommend screening at-risk children as young as two years old for latent tuberculosis (TB) infection.

DiviTum results from a large AstraZeneca study are presented today at the ASCO meeting in Chicago, the largest cancer congress in the world.

Egalet Corporation announced Bob Radie, president and chief executive officer, will present in panels at two upcoming conferences in June.

RDD Pharma announced the appointment of Dr. Mark Sirgo as the Chairman of the Board of Directors.

Codiak BioSciences, Inc announced the appointment of Richard Brudnick as Chief Business Officer and Head of Strategy.